GOLD BOND MEDICATED ANTI-ITCH CREAM 1 %
PRAMOXINE HYDROCHLORIDE : 1 % MENTHOL : 1 % · DIN 02236991 · SANOFI CONSUMER HEALTH INC
Health Canada status: MARKETED
What is GOLD BOND MEDICATED ANTI-ITCH CREAM?
GOLD BOND MEDICATED ANTI-ITCH CREAM 1 % contains PRAMOXINE HYDROCHLORIDE : 1 % MENTHOL : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02236991, held by SANOFI CONSUMER HEALTH INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 16-Dec-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02236991 |
|---|---|
| Brand name | GOLD BOND MEDICATED ANTI-ITCH CREAM |
| Generic / active ingredient | PRAMOXINE HYDROCHLORIDE : 1 % MENTHOL : 1 % |
| Manufacturer | SANOFI CONSUMER HEALTH INC |
| Strength | 1 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D04AB07 PRAMOCAINE |
| AHFS class | 84:08.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 16-Dec-2011 |
| Original market date | 1999-01-11 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D04AB07 PRAMOCAINE. 7 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AVEENO ANTI-ITCH LOTION | 1.0 % | LOTION | JOHNSON & JOHNSON INC | MARKETED | DIN 02240105 |
| GOLD BOND ANTI-ITCH LOTION | 5 % | LOTION | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 02318482 |
| ITCH RELIEF MOISTURIZING CREAM | 1 % | CREAM | CERAVE CANADA | MARKETED | DIN 02484889 |
| ITCH RELIEF MOISTURIZING LOTION | 1 % | LOTION | CERAVE CANADA | MARKETED | DIN 02486881 |
| POLYSPORIN ITCH RELIEF | 1.0 % | LOTION | JOHNSON & JOHNSON INC | MARKETED | DIN 02246156 |
| PRECISE COOLING PAIN RELIEF CREAM | 4 % | CREAM | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02547996 |
| AVEENO ANTI-ITCH CREAM | 1 % | CREAM | S.C. JOHNSON AND SON, LTD. | CANCELLED POST MARKET | DIN 02153653 |
| AVEENO ANTI-ITCH CREAM | 1.0 % | CREAM | JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02240104 |
| AVEENO ANTI-ITCH CREAM | 3 % | CREAM | S.C. JOHNSON AND SON, LTD. | CANCELLED POST MARKET | DIN 02068176 |
| AVEENO ANTI-ITCH LOTION | 3 % | LOTION | S.C. JOHNSON AND SON, LTD. | CANCELLED POST MARKET | DIN 02153645 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.